Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 | P41231 | 19/20 | 0.42 |
| ▸ | P2RY4 | P51582 | 6/20 | 0.42 |
| ▸ | FBP1 | P09467 | 1/20 | 0.41 |
| ▸ | P2RY6 | Q15077 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13259502 | 0.86 | FBP1 (0.53) | P2RY2P2RY4FBP1P2RY6 | |
| SCHEMBL26074117 | 0.86 | FBP1 (0.53) | P2RY2P2RY4FBP1P2RY6 | |
| SCHEMBL14985142 | 0.86 | FBP1 (0.53) | P2RY2P2RY4FBP1P2RY6 | |
| SCHEMBL23657026 | 0.83 | FBP1 (0.56) | P2RY2P2RY4FBP1P2RY6 | |
| SCHEMBL14985143 | 0.83 | FBP1 (0.56) | P2RY2P2RY4FBP1P2RY6 | |
| SCHEMBL24833618 | 0.79 | FBP1 (0.55) | P2RY2P2RY4FBP1P2RY6 | |
| SCHEMBL25719257 | 0.77 | FBP1 (0.34) | P2RY2P2RY4FBP1P2RY6 | |
| SCHEMBL14619450 | 0.76 | P2RY2 (0.53) | P2RY2P2RY4FBP1P2RY6 | |
| SCHEMBL25712624 | 0.74 | P2RY2 (0.37) | P2RY2P2RY4 | |
| SCHEMBL17732505 | 0.74 | P2RY2 (0.45) | P2RY2P2RY4FBP1P2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3131914-B1 | 3'-SUBSTITUTED METHYL OR ALKYNYL NUCLEOSIDES FOR THE TREATMENT OF HCV | IDENIX PHARMACEUTICALS LLC (US) | 2023-05-10 | — | — | EP | disclosed |